{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:08:56Z","timestamp":1783933736706,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.coi.2026.102791","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:04:49Z","timestamp":1780059889000},"page":"102791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel mechanisms linking platelet activation to antiphospholipid syndrome"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-7067","authenticated-orcid":false,"given":"Marina","family":"Camera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A","family":"Lonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier L","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102791_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102791_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.semarthrit.2018.08.004","article-title":"Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome","volume":"48","author":"Noureldine","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102791_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2026.102791_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.smim.2016.10.010","article-title":"Blood coagulation in immunothrombosis-at the frontline of intravascular immunity","volume":"28","author":"Gaertner","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2026.102791_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.coi.2026.102791_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.13248","article-title":"Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-\u03b22-GPI antibodies","volume":"196","author":"Capozzi","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102791_sbref7","first-page":"219","article-title":"Mechanisms sensitive to different drugs mediate a proadhesive and pro-thrombotic platelet phenotype in antiphospholipid syndrome","volume":"111","author":"Camera","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102791_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102791_bib9","article-title":"Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome","volume":"10","author":"Bala","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coi.2026.102791_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00001721-199810000-00013","article-title":"Platelet activation in patients with antiphospholipid syndrome","volume":"9","author":"Shechter","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.coi.2026.102791_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1599081","article-title":"Extracellular vesicles in the antiphospholipid syndrome","volume":"44","author":"Chaturvedi","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.coi.2026.102791_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/TH12-03-0212","article-title":"Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome","volume":"109","author":"Bontadi","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib13","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1007\/s10067-021-05843-z","article-title":"Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndrome","volume":"40","author":"Shi","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2026.102791_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2014.11.011","article-title":"Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations","volume":"135","author":"Chaturvedi","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.coi.2026.102791_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/jcm13030741","article-title":"Platelets and thrombotic antiphospholipid syndrome","volume":"13","author":"Tohidi-Esfahani","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2026.102791_sbref16","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1182\/bloodadvances.2025016162","article-title":"A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target","volume":"9","author":"NaveenKumar","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2026.102791_bib17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/jth.15724","article-title":"Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): role of P2Y","volume":"20","author":"Leonardi","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_sbref18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jtha.2025.01.020","article-title":"Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo","volume":"23","author":"Heimerl","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib19","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"379","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102791_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2013.08.015","article-title":"Receptors involved in cell activation by antiphospholipid antibodies","volume":"132","author":"Brandt","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.coi.2026.102791_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/jth.13314","article-title":"Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome","volume":"14","author":"Kolyada","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jth.15265","article-title":"Platelet Fc\u03b3RIIA in immunity and thrombosis: adaptive immunothrombosis","volume":"19","author":"Patel","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0038-1649646","article-title":"Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation","volume":"70","author":"Martinuzzo","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2141.1997.3063123.x","article-title":"Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome","volume":"98","author":"Godeau","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2026.102791_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.1997.2243038.x","article-title":"Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia","volume":"98","author":"Macchi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2026.102791_sbref26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1055\/a-2510-6147","article-title":"Association of specific antiphospholipid antibodies to platelet count and thrombocytopenia","volume":"125","author":"Griem","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/art.42801","article-title":"Calprotectin impairs platelet survival in patients with primary antiphospholipid syndrome","volume":"76","author":"Hoy","year":"2024","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.coi.2026.102791_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1947-2","article-title":"Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome","volume":"21","author":"Barbati","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102791_bib29","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/jth.13763","article-title":"Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study","volume":"15","author":"Hisada","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib30","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coi.2026.102791_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"von Hundelshausen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102791_bib32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3324\/haematol.2018.215145","article-title":"Appropriation of GPIb\u03b1 from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation","volume":"105","author":"Chimen","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102791_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.coi.2026.102791_bib34","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.41460","article-title":"Anti-neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102791_sbref35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1676578","article-title":"A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry","volume":"16","author":"Pine","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102791_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2025-001751","article-title":"Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews","volume":"12","author":"Mancuso","year":"2025","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.coi.2026.102791_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-05789-3","article-title":"Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions","volume":"7","author":"Tian","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.coi.2026.102791_bib38","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102791_bib39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2026.102791_sbref40","article-title":"Tissue factor, a membrane-associated marker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients","author":"Camera","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib41","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.coi.2026.102791_bib42","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102791_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-0035-1564041","article-title":"The role of tissue factor in atherothrombosis and coronary artery disease: insights into platelet tissue factor","volume":"41","author":"Camera","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.coi.2026.102791_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s44161-022-00021-z","article-title":"A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences","volume":"1","author":"Tyagi","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.coi.2026.102791_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1160\/TH14-10-0830","article-title":"Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation","volume":"114","author":"Brambilla","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102791_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/ATVBAHA.107.161471","article-title":"Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates","volume":"28","author":"Brambilla","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coi.2026.102791_bib47","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.ATV.0000085629.23209.AA","article-title":"Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs","volume":"23","author":"Camera","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coi.2026.102791_bib48","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/ATVBAHA.123.319099","article-title":"Cell surface platelet tissue factor expression: regulation by P2Y(12) and link to residual platelet reactivity","volume":"43","author":"Brambilla","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:41:20Z","timestamp":1783932080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S0952791526000683"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102791","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel mechanisms linking platelet activation to antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102791"}}